Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Time-dependent oral absorption models.

K Higaki1, S Yamashita, G L Amidon

  • 1College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065, USA.

Journal of Pharmacokinetics and Pharmacodynamics
|May 31, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to: Adult IgA vasculitis-look for triggers.

QJM : monthly journal of the Association of Physicians·2023
Same author

IgA vasculitis.

QJM : monthly journal of the Association of Physicians·2023
Same author

Mechanistic analysis and experimental verification of bicarbonate-controlled enteric coat dissolution: Potential in vivo implications.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2019
Same author

Mechanistic Oral Absorption Modeling and Simulation for Formulation Development and Bioequivalence Evaluation: Report of an FDA Public Workshop.

CPT: pharmacometrics & systems pharmacology·2017
Same author

In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context.

Molecular pharmaceutics·2017
Same author

Toward Biopredictive Dissolution for Enteric Coated Dosage Forms.

Molecular pharmaceutics·2016

New pharmacokinetic models using a time-dependent absorption rate coefficient, ka(t), accurately predict irregular drug absorption profiles. These advanced models, particularly the two-phase model with lag time (TPLAG), offer superior prediction compared to conventional methods for oral drug administration.

Area of Science:

  • Pharmacokinetics
  • Drug Absorption Modeling
  • Computational Pharmacology

Background:

  • Oral drug administration often results in complex plasma concentration-time profiles.
  • Conventional pharmacokinetic models struggle to interpret these irregular profiles due to fixed absorption kinetics and lag times.

Purpose of the Study:

  • To develop and evaluate novel pharmacokinetic models incorporating a time-dependent absorption rate coefficient, ka(t).
  • To compare the predictive performance of these new models against conventional models using propranolol plasma concentration data.

Main Methods:

  • Developed six new models with a time-dependent absorption rate coefficient, ka(t), to account for dynamic gastrointestinal processes.
  • Analyzed human plasma concentration-time profiles of propranolol using nonlinear regression analysis.
Keywords:
NASA Discipline Regulatory PhysiologyNon-NASA Center

Related Experiment Videos

  • Compared model performance using Akaike's Information Criterion (AIC) and sum of squares.
  • Main Results:

    • New models with ka(t) significantly outperformed the conventional compartment model with lag time (CLAG model).
    • The fluid absorption (FA) model showed the best overall fit based on AIC.
    • The two-phase model with lag time (TPLAG model) effectively described irregular profiles and predicted Cmax values well, demonstrating superior prediction of irregular absorption kinetics.

    Conclusions:

    • Incorporating a time-dependent absorption rate coefficient, ka(t), enhances the prediction of nonlinear drug absorption characteristics.
    • The TPLAG model is particularly effective for predicting complex and irregular oral drug absorption profiles.
    • These advanced models improve the reliability of pharmacokinetic analysis for orally administered drugs.